Related Experiment Videos
Lung cancer in the elderly patient
1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Clinics in Chest Medicine
|September 1, 1993
Summary
Lung cancer disproportionately affects older adults, with squamous cell carcinoma being the most common type in this demographic. Despite often presenting at earlier stages, elderly patients receive less treatment, missing opportunities for improved survival.
Area of Science:
- Geriatric Oncology
- Thoracic Oncology
- Epidemiology of Cancer
Background:
- Lung cancer is a leading cause of cancer-related mortality, particularly in individuals aged 65 and older.
- While adenocarcinoma is the most frequent histologic subtype in the general population, squamous cell carcinoma predominates in the elderly.
- Age-related factors influence lung cancer presentation and treatment patterns.
Purpose of the Study:
- To highlight the epidemiological characteristics of lung cancer in the elderly population.
- To examine the discrepancy between the stage of lung cancer at presentation and treatment rates in older adults.
- To underscore the potential for improved outcomes with timely and aggressive treatment in this age group.
Main Methods:
- Retrospective analysis of lung cancer patient data.
- Stratification of cases by age (≥65 years) and histologic subtype.
- Comparison of treatment modalities and survival rates across age groups.
Main Results:
- Approximately 50% of all lung cancer cases occur in patients aged 65 years and older.
- Squamous cell carcinoma is the most prevalent histologic type among elderly lung cancer patients.
- Elderly patients are less likely to receive treatment, even when diagnosed at less advanced stages and capable of tolerating aggressive therapies.
Conclusions:
- Lung cancer management in the elderly requires specific consideration due to distinct histologic patterns and treatment disparities.
- The under-treatment of elderly patients with lung cancer represents a significant challenge that may impede survival.
- Further research and clinical strategies are needed to optimize lung cancer care for older adults.